CORONARY HEART DISEASE: TREATMENT METHODS AND EFFICACY OF ANGINA MANAGEMENT
Keywords:
Coronary Heart Disease (CHD), Angina Pectoris, Quality of Life (QoL), Cardiac Self-Efficacy (CSE), Psychological Factors, Treatment Modalities, Pharmacological Interventions, Lifestyle Modifications, Health OutcomesAbstract
Coronary heart disease (CHD) is a leading cause of morbidity and mortality globally, yet effective management strategies for angina remain inadequately defined, creating a significant knowledge gap in optimal treatment approaches. This study conducted a comprehensive literature review of pharmacological treatments, lifestyle modifications, and surgical interventions for angina management, utilizing data from peer-reviewed articles published between 2010 and 2023. The findings indicate that a combination of antiplatelet agents, beta-blockers, nitrates, and lifestyle changes significantly reduces angina frequency and improves patient quality of life. Furthermore, surgical options like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) provide effective alternatives for patients with severe disease. These results underscore the importance of a multifaceted treatment approach tailored to individual patient needs, which could enhance clinical outcomes and inform future guidelines for CHD management.
References
1. Nair, T., Jadhav, U. M., Kumar, K. S., Manoria, P. C., Roy, D. G., Abdullakutty, J., & Patil, R. (2021). Consensus statement on holistic management of angina. J Assoc Physicians India, 69, 11-2.
2. Peterson, E.D. (2007). The burden of angina pectoris and its complications [corrected]. Clinical cardiology, 30 2 Suppl 1, I10-5.
3. Kloner, R.A., & Chaitman, B.R. (2017). Angina and Its Management. Journal of Cardiovascular Pharmacology and Therapeutics, 22, 199 - 209.
4. Theofilis, P., Oikonomou, E.K., Sagris, M., Papageorgiou, N., Tsioufis, K., & Tousoulis, D. (2023). Novel concepts in the management of angina in coronary artery disease. Current pharmaceutical design.
5. Sarkar, Urmimala MD, MPH; Ali, Sadia MD, MPH; Whooley, Mary A. MD. Self-Efficacy and Health Status in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study. Psychosomatic Medicine 69(4): p 306-312, May 2007. | DOI: 10.1097/PSY.0b013e3180514d57
6. Banik, A., Schwarzer, R., Knoll, N., Czekierda, K., & Luszczynska, A. (2018). Self-efficacy and quality of life among people with cardiovascular diseases: A meta-analysis. Rehabilitation Psychology, 63(2), 295–312. https://doi.org/10.1037/rep0000199
7. Wantiyah, W., Saputra, M. R., & Deviantony, F. (2020). Self-Efficacy and Health Status in Coronary Artery Disease Patients. Jurnal Ners, 15(1), 14–18. https://doi.org/10.20473/jn.v15i1.17628
8. Barham, A., Ibraheem, R. & Zyoud, S.H. Cardiac self-efficacy and quality of life in patients with coronary heart disease: a cross-sectional study from Palestine. BMC Cardiovasc Disord 19, 290 (2019). https://doi.org/10.1186/s12872-019-01281-7
9. Huth E.J., et al., "The introduction, methods, results, and discussion (IMRAD) structure," JAMA, 1988.
10. American Heart Association (AHA), "Heart Disease Statistics," 2023.
11. Fihn S.D., et al., "2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Management of Patients with Stable Ischemic Heart Disease," Circulation, 2014.
12. Knuuti J., et al., "2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes," European Heart Journal, 2020.
13. Stone G.W., et al., "Percutaneous Coronary Intervention for Stable Coronary Disease," New England Journal of Medicine, 2019.
14. McMurray J.J.V., et al., "ESC Guidelines for the diagnosis and management of acute heart failure," European Heart Journal, 2019.
